Fifty-six studies were included in the review: 35 of alternative airway devices (n=10,172 patients) and 21 of needle cricothyrotomy/surgical cricothyrotomy (n=512).
Pooled success rates were:
Oesophageal obturator airway-oesophageal gastric tube airway 92.6% (95% CI 90.1% to 94.5%, I2=62.5%; eight studies comprised nine data sets, n=1,833, quality score 2 to 8).
Pharyngeotracheal lumen airway 82.1% (95% CI 74% to 88%; one study, n=117, quality score 6).
Oesophageal-tracheal combitube 85.4% (95% CI 77.3% to 91%, I2=95%; 16 studies comprised 19 data sets, n=4,243, quality score 3 to 10).
Laryngeal mask airway 87.4% (95% CI 79% to 92.8%, I2=93.6%; 12 studies, n=3,829 patients, quality score 2 to 8).
King laryngeal tube airway 96.5% (95% CI 71.2% to 99.7%, I2=73.4%; three studies, n=150, quality score 3 to 7).
Needle cricothyrotomy 65.8% (95% CI 42.3% to 83.5%, I2=14.1%; four studies, n=27 patients, quality score 2 to 5).
Surgical cricothyrotomy 90.5% (95% CI 84.8% to 94.2%, I2=94.2%; 18 studies, n=485 patients, quality score 1 to 7).
Further subgroup analyses were detailed in the report.